April 16 2026
We are pleased to share the post from Alliance du Cœur ❤️, who—together with the Cardiology Department of CHU Rouen—is organizing a public awareness day on April 16 with free, walk‑in consultations to help detect heart valve diseases early:
This initiative strongly resonates with our mission at Cardiawave. Our Valvosoft® non-invasive ultrasound therapy for the treatment of aortic stenosis recently obtained its CE-Marking and can help patients who are not immediately eligible for current standard of care.
💡We are proud to collaborate with CHU Rouen and to support actions that bring prevention, early diagnosis, and innovative therapeutic options to the community.
💙Together, we continue advancing cardiovascular care and improving patient outcomes.
@Alliance du Cœur @CHU Rouen #StructuralHeart #Innovation #AorticStenosis #CardiovascularInnovation #Valvosoft #medtech #focusedultrasound #innovation #NIUT #TAVI #TAVR #AorticValve #lifetimemanagementofas #valves #CEMarking
